Image-guided radiation therapy vendor ViewRay reported preliminary revenue increases for its fourth quarter and fiscal year 2021.
For the quarter (end-December 31), ViewRay's revenue was approximately $20 million, up 11% from $18 million in the same period in 2020. For the full year, the company posted revenues of approximately $70 million, up 23% from last year's $57 million.
The company said it also received seven new orders for its MRIdian MRI-guided radiation therapy system in 2021, compared with five new orders in the same period in 2020. For the year, it received 28 new orders for systems -- an increase of 65% compared with 17 new orders in 2020.
